Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study

Journal of Internal Medicine

Volumn 247, Issue 2, 2000, Pages 205-212

  Gram, Jorgen ^a,b   Bladbjerg, E M ^a   Moller L ^c   Sjol A ^c   Jespersen, Jorgen ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c NONE

Author keywords

C reactive protein; Case control study; Coronary heart disease; Tissue type plasminogen activator

Indexed keywords

C REACTIVE PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBRINOLYSIS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY DISEASE; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ROC CURVE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033953005     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00604.x     Document Type: Article

References (19)

1. 1 Cram J, Jespersen J, Kluft C, Rijken D. On the usefulness of fibrinolysis variables in the characterization of a risk group among survivors of acute myocardial infarction. Acta Med Scand 1987; 221: 149-53.
2. 2 Olofsson B-O, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator and tissue plasminogen activator in patients with angiographically verified coronary artery disease. Eur Heart J 1989; 10: 77-82.
3. 3 Cortellaro M, Cofrancesco E, Boschetti C et al. Increased fibrin turnover and high PAI-1 activity as predictors of ischaemic events in atherosclerotic patients. Arterioscler Thromb 1993; 13: 1412-7.
4. 4 Jansson J-H, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993; 88: 2030-4.
5. 5 Ridker PM. Vaughan DE, Stampfer MJ, Manson JE, Hennekcns CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
6. 6 Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
7. 7 Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996; 94: 2057-63.
8. 8 Astrup T. The biological significance of fibrinolysis. Lancet 1956; 2: 565-8.
9. 9 Kuller LH, Tracy RP, Shaten J. Meilahn EN. Relation of C-reactive protein and coronary heart disease in MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-47.
10. 10 Tracy RP, Lemaitre RN, Psaty BM et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Arterioscler Thromb Vase Biol 1997; 17: 1121-7.
11. 11 Haverkate F, Thompson SG, Pyke SDM. Gallimore JR. Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997 349;:462-6.
12. 12 Anzai T, Yoshikawa T, Shiraki H et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first q-wave acute myocardial infarction. Circulation 1997: 96: 778-84.
13. 13 Ridker PM, Cusbman M. Stampfer MJ, Tracy RP, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
14. 14 Sjol A, Grunnet K, Scholl M. Secular trends in serum cholesterol, high density lipoproteins and triglycerides 1964-87. Int J Epidemiol 1991; 20: 105-13.
15. 15 Rose GA, Blackburn H, Gillum RF, Princas RJ. Cardiovascular Survey methods. Geneva, Switzerland: World Health Organization, 1982.
16. 16 Astrup T. Role of Blood Coagulation and Fibrinolysis in the Pathogenesis of Arteriosclerosis. New York, USA: Academic Press, 1959.
17. 17 Smith FB, Lee AJ. Fowkes FGR, Price JF, Rumley A, Lowe GDO. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-5.
18. 18 Van der Bom JG. de Knijff P, Haverkate F et al. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 1997; 95: 2623-7.
19. 19 Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993; 30: 521-39.